title: Sorafenib prolongs survival, but what happens to the symptoms?
authors.forename: Bruno M
authors.initials: BM
authors.lastname: Strebel
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004317:Doxorubicin / Q000627:therapeutic use*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D011725:Pyridines / Q000627:therapeutic use*
chemical_list: D000903:Antibiotics, Antineoplastic; D001557:Benzenesulfonates; D011725:Pyridines; D004317:Doxorubicin